Tr1X
CA - San DiegoBiotechnology
Focus: Tr1X is a public-stage biotechnology company headquartered in San Diego specializing in regulatory T cell (Treg)-based immunotherapies for autoimmune and inflammatory diseases. The company operates as a focused pipeline-stage biotech with early-stage programs in immunology.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
7+4 this month
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Should You Work at Tr1X?
AI assessmentTr1X offers high scientific upside and hands-on impact for early-career scientists, but limited headcount and pre-commercialization status carry execution and cash-runway risk.
Why Work Here
- Access to cutting-edge Treg cell therapy platform with recent Phase 1 clinical validation (TRX103 for GvHD showed promise as of Feb 2026).
- Early-stage company offers rapid skill-building and broad functional impact across R&D, regulatory, and supply chain roles.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TRX103
Hematologic MalignancyClinical Trials (1)
NCT06462365Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Phase 1Help build intelligence for Tr1X
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.